Micro Emerging Active

ImmunityBio FDA warning letter

评分
0.4
动能
▲ 0.0
文章
4
来源
1

摘要

An article belongs to this narrative if it discusses the FDA warning letter received by ImmunityBio.

相关文章

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · 三月 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · 三月 24, 2026
Bearish

来源

Jim Cramer on ImmunityBio: “I Would Encourage You to Own … Yahoo Finance
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy … Yahoo Finance
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include … Yahoo Finance
Why ImmunityBio Stock Is Down More Than 20% Today Yahoo Finance

时间线

最后更新 三月 24, 2026